With the Neuromodulation market surpassing $7B by 2025, the mysteries behind this med-tech are revealed. Hear from industry leaders how this emerging technology is tackling everything from chronic pain, parkinson’s and sleep apnea to epilepsy, paralysis, stroke, incontinence and depression.
Closing Keynote — Cutting-edge Neuromodulation Tackles Disease on All Fronts
Sr. Vice President North America
Director, Neuromodulation Research & Development
VP Product Development
Vice President and General Manager Pain Stimulation & Early Interventions Medtronic Pain Therapies